💊
Cinryze
C1 inhibitor (human)
Angioødem, arveligt
✅ Autoriseret
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
⚠️ Patient sikkerhed
No
📚 Tidligere alarmer (2)
Officiel EMA-side
https://www.ema.europa.eu/en/medicines/human/EPAR/cinryze